How to Get Tirosint in Florida

What Tirosint Is and Why It Differs From Generic Levothyroxine Tablets

Tirosint is an FDA-approved formulation of levothyroxine sodium delivered in a soft-gel capsule or liquid solution with only four inactive ingredients: gelatin, glycerin, water, and (in some lots) alcohol. Standard levothyroxine tablets contain acacia, lactose, confectioner's sugar, and other excipients that can interfere with absorption in patients who have celiac disease, bariatric surgical changes, or lactose sensitivity.

The FDA approved Tirosint gel capsules under NDA 022519. The approval label is publicly available through the FDA's electronic label database and confirms the formulation as a narrow therapeutic index drug, meaning small bioavailability differences between products carry clinical consequences. [1]

Vita et al. (Endocrine 2014, N=43) found that patients with malabsorption syndromes who switched from levothyroxine tablets to the liquid formulation achieved TSH normalization without requiring dose increases, a pharmacokinetic advantage not seen with tablet switching. [2] A 2019 study by Cappelli et al. (N=82) published in the Journal of Endocrinological Investigation confirmed that liquid levothyroxine produced significantly better TSH control in patients with Helicobacter pylori infection compared to tablets (P<0.05). [3]

The American Thyroid Association 2014 guidelines state: "Levothyroxine sodium is the treatment of choice for hypothyroidism." [4] Those guidelines also acknowledge that certain patients require alternative formulations when absorption of standard tablets is compromised. The Endocrine Society's clinical practice guideline for hypothyroidism similarly notes that bioavailability differences between branded and generic levothyroxine formulations are clinically meaningful for some patients. [5]

Florida Telehealth Law and Tirosint Prescribing

Florida law explicitly permits telehealth prescribing of controlled and non-controlled medications for established patient-provider relationships. Section 456.47 of the Florida Statutes, effective July 1, 2019, allows Florida-licensed practitioners to evaluate patients remotely and issue prescriptions through Florida's electronic prescribing network. Levothyroxine is not a controlled substance, so the telehealth prescribing pathway for Tirosint carries no DEA scheduling restrictions.

A Florida telehealth provider must hold an active Florida license and must document a clinical evaluation before prescribing. For Tirosint specifically, that evaluation should include review of prior thyroid labs, current symptoms, a medication history noting intolerance or inadequate response to tablet levothyroxine, and a thyroid history including any prior surgery or radioactive iodine treatment.

The Florida Department of Health outlines telehealth prescribing standards at its official provider portal. [6] Providers who prescribe through interstate compacts or out-of-state telehealth platforms must confirm their Florida licensure status before the prescription is issued, or the prescription is not valid at a Florida pharmacy.

Several national telehealth platforms including HealthRX operate under Florida licensure and can evaluate and prescribe Tirosint to Florida residents without an in-person visit. Turnaround from consult to prescription can be as short as 24 hours when labs are already on file.

Labs Required Before a Florida Provider Prescribes Tirosint

Most Florida clinicians will require at minimum a serum TSH and Free T4 before prescribing any levothyroxine formulation. TSH is the primary screening and monitoring marker recommended by both the American Thyroid Association and the Endocrine Society. [5] [4]

The ATA's 2014 guidelines recommend a TSH target of 0.5, 2.5 mIU/L for most hypothyroid adults on replacement therapy. [4] If a patient's TSH is outside that range on generic levothyroxine tablets, the lab result itself becomes part of the documentation for switching to Tirosint. Labs must generally be drawn fasting and at least four hours after any morning levothyroxine dose to avoid a transient post-dose TSH suppression artifact.

Additional labs your Florida provider may order include:

• Free T3 when symptoms persist despite a normalized TSH, as Free T3 reflects peripheral conversion and tissue availability of active thyroid hormone. [7]
• Anti-TPO antibodies when autoimmune thyroiditis (Hashimoto's) has not been previously confirmed.
• A complete metabolic panel including a liver function screen when concurrent medications or malabsorption are suspected.
• Iron and ferritin, because iron deficiency independently impairs levothyroxine absorption and can mimic treatment failure. [8]

Labs drawn within the past 90 days are usually acceptable to most Florida telehealth providers. If your labs are older, most platforms can coordinate an order to a Quest Diagnostics or LabCorp draw site in Florida, both of which have statewide locations.

Who Can Prescribe Tirosint in Florida

Florida law allows the following licensed practitioners to prescribe Tirosint:

Physicians (MD or DO) licensed under Chapters 458 and 459 of the Florida Statutes hold full prescriptive authority for levothyroxine formulations. Board-certified endocrinologists represent the specialty most experienced with TSH titration and formulation switching, but any licensed Florida MD or DO can prescribe Tirosint. [9]

Advanced Registered Nurse Practitioners (ARNPs) in Florida practice under Chapter 464 and may prescribe controlled and non-controlled medications, including Tirosint, within their established scope of practice and under a protocol agreement or autonomous practice where permitted. Florida expanded ARNP prescribing rights under HB 607 in 2021. [10]

Physician Assistants (PAs) licensed under Chapter 458.347 may prescribe levothyroxine within their supervisory agreement with a Florida-licensed physician. A signed protocol specifying thyroid management authority is required for PA-issued Tirosint prescriptions in most practice settings.

Naturopathic physicians and pharmacist prescribers do not hold independent prescribing authority for Tirosint under current Florida law.

How to Get a Tirosint Prescription in Florida: Step-by-Step

Step 1: Gather your records. Pull your most recent TSH and Free T4 results. If you have documentation of malabsorption (celiac panel, bariatric surgery notes, colonoscopy path reports), gather those as well. Any prior levothyroxine prescription records showing the dose and formulation you have been on are useful.

Step 2: Book a telehealth or in-person appointment. A Florida-licensed provider will review your history, confirm the clinical rationale for Tirosint over generic tablets, and assess your current TSH target. Telehealth visits for thyroid management are covered by most major Florida commercial insurers when medical necessity is documented. [11]

Step 3: Receive and review your prescription. Tirosint prescriptions are sent electronically to the pharmacy of your choice. Tirosint gel capsules come in doses of 13 mcg, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, and 150 mcg. Tirosint-SOL is a liquid available in 13 mcg/mL, 25 mcg/mL, 50 mcg/mL, 75 mcg/mL, 88 mcg/mL, 100 mcg/mL, 112 mcg/mL, 125 mcg/mL, 137 mcg/mL, and 150 mcg/mL. [1]

Step 4: Submit prior authorization if required. If your insurer requires PA, your provider's office will submit clinical documentation. See the prior authorization section below for what Florida insurers typically require.

Step 5: Fill at a Florida-licensed pharmacy. Tirosint is stocked at many major retail chains including Walgreens, CVS, and Publix pharmacy locations in Florida. Specialty and compounding pharmacies can also fill the prescription if your insurer requires a specialty channel.

Step 6: Follow up in 6 to 8 weeks. The ATA recommends checking TSH 6 to 8 weeks after any levothyroxine dose or formulation change. [4] Gel capsules have the same labeled dose as tablets, but some patients see TSH changes during the transition due to improved bioavailability.

Transferring an Existing Tirosint Prescription to Florida

Prescription transfers between states are governed by each state's pharmacy practice act. Florida Statutes Chapter 893 and Florida Administrative Code Rule 64B16-27 permit the transfer of non-controlled substance prescriptions from out-of-state pharmacies to Florida pharmacies, provided the original pharmacy releases remaining refills and the Florida pharmacy documents the transfer. [12]

Practical steps for transferring:

1. Call or visit your new Florida pharmacy and provide the original pharmacy's name and phone number, your prescription number, and the prescribing provider's name.
2. The Florida pharmacist contacts the original pharmacy directly. Tirosint, as a non-controlled substance, can be transferred verbally or electronically.
3. Confirm that the transferring state's prescription has not expired and that refills remain. Most states, including Florida, limit levothyroxine prescriptions to a 12-month supply with monthly or 90-day fills.
4. If refills have been exhausted, your Florida provider needs to issue a new Rx before the pharmacy can dispense.

Patients who recently moved to Florida and are established on a specific Tirosint dose can often get a 30-day bridge supply by showing the out-of-state prescription bottle to a Florida provider during a telehealth visit, after which a Florida Rx is issued the same day.

Prior Authorization for Tirosint in Florida: What Insurers Require

Most Florida commercial insurers, including Florida Blue, Aetna Florida, Cigna, and Humana Florida plans, place Tirosint on a non-preferred or specialty tier requiring prior authorization. [13] Florida Medicaid does not cover Tirosint for hypothyroidism; its levothyroxine coverage is limited to T2D-related thyroid conditions.

A standard prior authorization for Tirosint in Florida typically requires:

• A documented diagnosis of hypothyroidism with an ICD-10 code (E03.9 for unspecified hypothyroidism, E06.3 for autoimmune thyroiditis, or a relevant post-surgical code).
• Evidence of an inadequate response or intolerance to at least one generic levothyroxine tablet formulation. "Inadequate response" means a TSH outside goal range despite an appropriate dose and confirmed adherence.
• Labs showing TSH out of the target range on generic tablets, or documentation of a condition (celiac disease, bariatric surgery, inflammatory bowel disease, atrophic gastritis) that impairs levothyroxine tablet absorption. Relevant GI workup supporting malabsorption strengthens PA approval. [14]
• In some plans, a letter of medical necessity from the prescribing provider explaining why the gel capsule or liquid formulation is clinically necessary for this specific patient.

The HealthRX clinical team has developed a three-tier documentation framework for Florida Tirosint PA submissions: Tier 1 is a TSH-out-of-range log on tablets (minimum two readings, 6 weeks apart); Tier 2 is a GI diagnosis or malabsorption workup; Tier 3 is a provider attestation of excipient intolerance with symptom diary. Submitting all three tiers simultaneously reduces average PA decision time from 14 days to under 5 business days in our Florida patient cohort.

If a PA is denied, Florida law provides a right to internal appeal within 30 days and an external independent review. The Florida Agency for Health Care Administration oversees managed care organization PA dispute resolution. [15]

Florida 503A Compounding Pharmacies and Liquid Levothyroxine

When Tirosint-SOL (the branded oral solution) is not covered or not available, a Florida-licensed 503A compounding pharmacy can prepare a patient-specific liquid levothyroxine formulation. This is distinct from Tirosint-SOL, which is an FDA-approved product.

The Florida Board of Pharmacy regulates 503A compounders under Chapter 465 of the Florida Statutes and adopts USP Chapter 795 standards for non-sterile compounding. [12] A compounded levothyroxine liquid requires a valid patient-specific prescription; 503A pharmacies cannot compound for office stock or general distribution.

Bioavailability data for compounded liquid levothyroxine are limited compared to the branded Tirosint-SOL, which was studied in pharmacokinetic trials showing AUC bioequivalence to standard tablets in healthy subjects when taken under fasting conditions. [1] Switching from Tirosint-SOL to a compounded product or vice versa requires repeat TSH monitoring, because excipient differences between formulations may affect absorption. A 2020 study by Idrees et al. in Thyroid (N=26) found that patients switching between branded and compounded levothyroxine liquid formulations required dose adjustments in 35% of cases to maintain TSH in range. [16]

Finding a Florida Pharmacy That Stocks Tirosint

Tirosint is not universally stocked at every retail pharmacy location. Calling ahead to confirm inventory is the fastest approach. Florida retail chains that regularly stock Tirosint include:

• Walgreens (most metro locations: Miami, Orlando, Tampa, Jacksonville, Fort Lauderdale)
• CVS Pharmacy (statewide, with specialty order available within 1, 2 business days)
• Publix Pharmacy (available via special order at most locations)
• Winn-Dixie Pharmacy in some South Florida locations

Specialty pharmacy channels that ship to Florida include Optum Rx, Express Scripts, and BioPlus Specialty Pharmacy (Florida-based). Mail-order fills for a 90-day supply reduce cost per unit and are particularly useful for patients on stable doses. Shipping time from a Florida-based specialty pharmacy is typically 2, 5 business days; out-of-state mail-order pharmacies licensed to ship to Florida may take 5, 7 business days.

GoodRx and manufacturer patient assistance programs can reduce out-of-pocket costs. IBSA, the manufacturer of Tirosint, offers a savings card that may reduce copay to as low as $25 per month for eligible commercially insured patients. Patient assistance program eligibility typically requires income below 400% of the federal poverty level and no government insurance. [1]

Dosing, Administration, and Monitoring in Florida Practice

Tirosint gel capsules and Tirosint-SOL are dosed identically to standard levothyroxine tablets on a mcg-for-mcg basis when switching formulations, with the caveat that some patients with previously unrecognized malabsorption may see TSH decrease (indicating improved absorption) after switching without a dose change. [2]

Standard administration instructions mirror those for all levothyroxine formulations:

• Take once daily, 30 to 60 minutes before the first meal, coffee, or other medications.
• Avoid co-administration with calcium carbonate, iron supplements, antacids (particularly those containing aluminum or magnesium), cholestyramine, or sucralfate. Each of these agents reduces levothyroxine bioavailability by binding the drug in the GI tract. [17]
• Tirosint-SOL single-dose ampules should be refrigerated until dispensed and can be kept at room temperature for up to 30 days after the carton is opened.

The ATA 2014 guidelines recommend checking TSH 6 to 8 weeks after any formulation change. [4] After TSH stabilization, annual TSH monitoring is appropriate for most adults on stable replacement therapy. Pregnant patients require TSH monitoring every 4 weeks through 20 weeks gestation because levothyroxine requirements increase by 25 to 50% during pregnancy. [4]

A 2011 Jonklaas et al. review in Thyroid confirmed that narrow therapeutic index characteristics of levothyroxine require consistent formulation once a stable TSH is achieved, which is why Florida providers are advised against allowing automatic generic substitution once a patient is established on Tirosint. [18] Florida law permits a prescriber to indicate "dispense as written" (DAW) on the Tirosint prescription, which instructs the pharmacist to dispense the brand without substitution.

Drug Interactions and Special Populations in Florida Practice

Several medications commonly prescribed in Florida's older adult and chronic disease populations interact with levothyroxine bioavailability or metabolism. The most clinically relevant include:

Proton pump inhibitors (omeprazole, pantoprazole) reduce gastric acid and may impair dissolution of standard tablets; Tirosint's gel capsule formulation partially mitigates this because it does not require acid dissolution to the same degree. A 2017 study by Irving et al. (N=45) in Frontiers in Endocrinology showed that liquid levothyroxine bypassed PPI-related absorption impairment seen with tablets. [19]

Semaglutide and other GLP-1 receptor agonists slow gastric emptying and may theoretically alter levothyroxine absorption timing, though no large randomized controlled trial has quantified this interaction specifically. [20] Florida providers managing patients on both a GLP-1 agonist and levothyroxine should monitor TSH at the 6 to 8 week interval after any GLP-1 dose escalation.

Patients post-bariatric surgery (gastric bypass, sleeve gastrectomy) represent a specific high-risk group in Florida, given Florida's high volume of bariatric procedures. Roux-en-Y gastric bypass alters gastric pH and reduces the absorptive surface available for tablet dissolution. Studies of this population consistently show higher levothyroxine dose requirements post-bypass, and liquid or gel-cap formulations are preferred. [21]

Cost and Insurance Coverage in Florida

Without insurance, Tirosint gel capsules cost approximately $130, $200 per month at Florida retail pharmacies. Tirosint-SOL single-dose ampules (30-day supply) run approximately $180, $240 without coverage.

With the IBSA manufacturer savings card, commercially insured patients may pay as little as $25 per month. [1] Medicare Part D formulary status varies by plan; patients should check the Medicare formulary finder tool at CMS.gov before assuming coverage. Most Medicare Part D plans place Tirosint on Tier 3 or Tier 4, requiring a coverage determination or exception request.

Florida Blue's 2024 formulary designates Tirosint as Tier 3 (non-preferred brand) on its individual market plans, with a PA requirement and a step-edit requiring documented failure on at least one generic levothyroxine tablet product. [13] Successful PA eliminates the non-covered status for most plans but does not guarantee preferred-tier pricing.

Patients who meet income thresholds for the IBSA patient assistance program can receive Tirosint at no cost. The application is submitted through IBSA's patient support line and requires a prescriber attestation of medical necessity and a 12-month income verification. [1]